In this Bottom Line Blog post, Dr. Diane Palmieri, director of NCI’s Center for Research Strategy, spotlights major goals from the NCI Fiscal Year 2026 Annual Plan and Professional Judgment Budget Proposal. She emphasizes NCI’s strong support for early-stage investigators and the importance of engaging every person to end cancer as we know it for all people. https://go.nih.gov/bw1SOv1 #NCIFuture
National Cancer Institute (NCI)
Government Administration
Bethesda, MD 307,984 followers
The National Cancer Institute, part of the National Institutes of Health, is the lead federal agency for cancer research
About us
The National Cancer Institute (NCI), part of the National Institutes of Health, is the lead federal agency for cancer research. For more information about NCI, visit us at www.cancer.gov. Privacy policy: https://www.cancer.gov/policies/privacy-security Engagement ≠ endorsement
- Website
-
http://www.cancer.gov
External link for National Cancer Institute (NCI)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Specialties
- cancer, cancer research, cancer training, cancer research grants, cancer resources, cancer information, and cancer research funding
Locations
-
Primary
9000 Rockville Pike
Bethesda, MD 20892, US
-
9609 Medical Center Drive
Rockville, MD 20850, US
-
Ft. Detrick U.S. Army Facility
Frederick, MD, US
Employees at National Cancer Institute (NCI)
Updates
-
Within NCI's Division of Epidemiology and Genetics, fellows are an integral part of the interdisciplinary teams conducting cutting-edge research. Learn about different aspects of becoming a fellow and how NCI is working to create a workforce for the future. https://go.nih.gov/9Muunjz #NationalCancerPlan
Optimizing the Workforce: Fellows
dceg.cancer.gov
-
In 2023, scientists developed a blood test that, in a preliminary study, accurately detected liver cancer, including in people with early stages of the disease. Unlike most other blood tests in development for cancer detection, this one uses a new type of technology, called fragmentomics, to analyze bits of DNA in the blood. Read more: https://go.nih.gov/3g9DQzI
-
Join in the cancer research conversation when you attend an upcoming NCI event! Check out these events coming up: 1. On October 8, NCI's Childhood Cancer Data Initiative is offering a webinar about NCI’s Pediatric Proton and Photon Therapy Comparison Cohort. This webinar explores this multi-center study’s design, current enrollment status, and state-of-the-art methods—to determine a participant’s amount of radiation exposure. https://go.nih.gov/7NeN90g #Data4ChildhoodCancer 2. Quantum computing has the potential to introduce new computational methods capable of overcoming persistent hurdles to progress in biomedical research, providing new avenues for the study of complex biological questions. Apply by October 13 to join an upcoming NIH Innovation Lab designed to advance the development of quantum computing approaches for biomedical applications. https://go.nih.gov/eT22dnP #QuantComputing4Biomedicine 3. On October 15-16, the NCI is excited to host the 2nd Annual Data Sharing Symposium, "Driving Cancer Advances through Impactful Research." This hybrid event will cover the broad impact of data sharing, exploring a learning health system for cancer, looking ahead to the impact of AI, improving data access, and more. Register here to attend in-person or online: https://go.nih.gov/a7UYnzc 4. Save the date for the upcoming Cancer Research Data Commons (CRDC) 2024 Fall Symposium, which will be held October 16-17. This event will include informative sessions and report-outs on new work, including our AI Data Readiness Initiative and the CRDC’s collaboration with the Advanced Research Projects Agency for Health (ARPA-H) to develop a Biomedical Data Fabric Toolbox. https://go.nih.gov/safJ3vE #DataScience
-
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer, is the most common inherited genetic change that increases the risk of several kinds of cancer including colorectal cancer. About 3% of all colorectal cancers in the U.S. occur in people with these inherited genetic changes; more than 1 million people in the U.S. have this syndrome. https://go.nih.gov/vad5s5g Media Description: Lynch syndrome pedigree. This pedigree shows some of the classic features of a family with Lynch syndrome, including affected family members with colon cancer or endometrial cancer and a younger age at onset in some individuals.
-
In the U.S., breast cancer is the second most common cancer in women after skin cancer. Our expert-reviewed overview has information about many aspects of the disease, including prevention, screening, and treatment: https://go.nih.gov/C4Xnncg
-
The Advanced Research Projects Agency for Health (ARPA-H) has launched an initiative for early career researchers and community health centers. The initiative aims to increase access to government research funding and address health care gaps in the United States. Learn more. https://go.nih.gov/kttW9HL
ARPA-H launches initiative for early career researchers and community health centers
arpa-h.gov
-
PRESS RELEASE: Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by researchers at the National Institutes of Health (NIH). However, there was little evidence of a rebound in incidence that would account for the decline in diagnoses in 2020, when screening and other medical care were disrupted. https://go.nih.gov/gZW8kLE
-
“When you go through cancer as a child, it’s incredibly difficult to stay a child,” said Kamalani, who was diagnosed with acute lymphoblastic leukemia at 5 years old. A recent college graduate, Kamalani hopes that researchers keep working toward a better understanding of long-term side effects and "create effective plans to get the jump on cancer.” Better data sharing could help make this hope a reality. Read Kamalani’s story: https://go.nih.gov/CF5N6x8
-
NCI Center for Cancer Research's Dr. Steven Rosenberg was presented with a milestone award for 50 years of excellent service to NCI last week. His pioneering work in immunotherapy has touched lives, inspired researchers, and transformed our field.